Navigation Links
Prometheus Research Signs 3-Year Contract With Simons Foundation to Expand HTSQL Informatics System for Autism Research
Date:6/2/2009

SFARI Base to Usher in 'New Paradigm of Research Collaboration'

NEW HAVEN, Conn., June 2 /PRNewswire/ -- Prometheus Research has signed a three year contract with the New York-based Simons Foundation to expand their development partnership on SFARI Base, the HTSQL-based informatics platform that helps researchers collaborate on understanding the causes of autism. The collaboration is part of the Simons Foundation Autism Research Initiative (SFARI).

Prometheus, a database management software company headquartered here, created the groundbreaking HTSQL platform, which allows for real-time access and configuration of databases via the web. Their flagship product for the biomedical research market, RexDB(R), formed the basis for SFARI Base, and is already used by over a dozen leading research universities, such as Harvard, Yale, Columbia, and the University of California - Los Angeles.

"Prometheus Research and its HTSQL web-based database software are enabling researchers to usher in a new paradigm of research collaboration with SFARI Base," said Stephen B. Johnson PhD, Associate Professor, Biomedical Informatics, Columbia University, working with the Simons Foundation. "This web-based tool offers researchers unprecedented access to DNA specimens on affected families, combined with high quality phenotype data," Johnson said.

The SFARI mission is to improve the diagnosis, treatment, and prevention of autism and related developmental disorders. The SFARI database, known as SFARI Base, is a new resource for autism research that provides the scientific community access to genetic and phenotypic information on 2000 families.

"Researchers need flexible, adaptive, and secure informatics systems that empower them to uncover critical data easily, from wherever they are, over the web," said Leon Rozenblit, president, Prometheus Research. "HTSQL enables us to quickly and efficiently develop customized solutions that increase organizational intelligence, save time, and save money by making data a shared resource that collaborators can access as needed."

About Prometheus Research

Prometheus Research, New Haven, Conn., is a software development and professional services company innovating web-based tools to empower knowledge workers by making existing databases easily available on the web. Prometheus HTSQL quickly translates the language of the web (HTTP) into the language of databases (SQL), allowing businesses and organizations to securely increase their intelligence through dynamic, real-time, web-based database management. Prometheus RexDB(R), a biomedical application, is used by world-renowned researchers and simplifies development of custom informatics systems for secure access to rich scientific data. For more information, go to www.prometheusresearch.com.


'/>"/>
SOURCE Prometheus Research
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Prometheus Licenses COLAL-PRED(R) From Alizyme
2. Prometheus Strengthens Intellectual Property Portfolio with Newly Issued Patents for Thiopurine Metabolite Testing
3. Prometheus Receives New York State Approval for PROMETHEUS(R) IBS Diagnostic, First Blood Test for Irritable Bowel Syndrome
4. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
5. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
6. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
7. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
8. Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Target Price
9. eResearchTechnology to Present at the Thomas Weisel Healthcare Conference 2007 on September 5th
10. The Debiopharm Life Sciences Award Goes to Dr Nusser for his Outstanding Research in Neuroscience
11. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... , Feb. 12, 2016  PTC Therapeutics, Inc. ... annual STRIVE (Strategies to Realize Innovation, Vision and ... (DMD). STRIVE provides funds to patient advocacy organizations ... make meaningful contributions to the rare disease community ... of future patient advocates. Mary ...
(Date:2/11/2016)... NBIX ) today announced its financial results for the quarter ... --> For the fourth quarter of 2015, the ... per share, compared to a net loss of $19.4 million, or ... the year ended December 31, 2015, the Company reported a net ... to a net loss of $60.5 million, or $0.81 loss per ...
(Date:2/11/2016)... , Feb. 11, 2016  Bioethics International, a not-for-profit organization ... researched, developed, marketed and made accessible to patients around the ... had named the publication of the Good Pharma ... publication is also featured as one of BMJ Open ... last year that are most frequently read. Ed ...
(Date:2/11/2016)... (PRWEB) , ... February 11, ... ... business-to-business publication dedicated to delivering cutting-edge information focused on the development and ... Sciences to become a premier sponsor of the 2016 BioProcess International Awards ...
Breaking Biology Technology:
(Date:1/18/2016)... JOSE, Calif. , Jan. 18, 2016 /PRNewswire/ ... security software that simplifies the use and access ... technology and go-to-market partnership with American Cyber.  ... Cyber brings extensive experience leading transformational C4ISR and ... implementing and integrating the latest proven technology solutions," ...
(Date:1/13/2016)... ALBANY, New York , January 13, 2016 /PRNewswire/ ... Transparency Market Research has published a new market report ... Share, Growth, Trends, and Forecast, 2015 - 2023. According to ... mn in 2014 and is anticipated to reach US$1,625.8 ... from 2015 to 2023. In terms of volume, the ...
(Date:1/11/2016)... , Jan. 11, 2016 Synaptics Incorporated ... interface solutions, today announced that its ClearPad ® ... (TDDI) products won two separate categories in the 8 ... Innovator and Best Technology Breakthrough. The Synaptics ® ... a simplified supply chain, thinner devices, brighter displays and ...
Breaking Biology News(10 mins):